TG THERAPEUTICS, INC. Amortization of Lease Incentives
TG THERAPEUTICS, INC. (TGTX) reported Amortization of Lease Incentives of $106.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeaseIncentives · last filed 2021-08-06
- TG THERAPEUTICS, INC. amortization of lease incentives for the quarter ending 2021-06-30 was $53.00K, a 5.36% decline year-over-year.
- TG THERAPEUTICS, INC. amortization of lease incentives for the quarter ending 2021-03-31 was $53.00K, a 1.85% decline year-over-year.
- TG THERAPEUTICS, INC. amortization of lease incentives for the quarter ending 2020-12-31 was $53.00K, a 17.78% increase year-over-year.
- TG THERAPEUTICS, INC. amortization of lease incentives for the quarter ending 2020-09-30 was $53.00K, a 15.22% increase year-over-year.
- TG THERAPEUTICS, INC. amortization of lease incentives for fiscal 2020 was $216.00K, a 18.68% increase from fiscal 2019.
- TG THERAPEUTICS, INC. amortization of lease incentives for fiscal 2019 was $182.00K, a 34.81% increase from fiscal 2018.
- TG THERAPEUTICS, INC. amortization of lease incentives for fiscal 2018 was $135.00K, a 8.00% increase from fiscal 2017.
- TG THERAPEUTICS, INC. amortization of lease incentives for fiscal 2017 was $125.00K.
| Period end | Amortization of Lease Incentives 3 month | Amortization of Lease Incentives 6 month | Amortization of Lease Incentives 9 month | Amortization of Lease Incentives 12 month |
|---|---|---|---|---|
| 2021-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $106.00K 10-Q · filed 2021-08-06 | $159.00K derived: sum of 3 quarters · filed 2021-08-06 | $212.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | $53.00K 10-Q · filed 2021-05-10 | $106.00K derived: sum of 2 quarters · filed 2021-05-10 | $159.00K derived: sum of 3 quarters · filed 2021-05-10 | $215.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $106.00K derived: sum of 2 quarters · filed 2021-03-01 | $162.00K derived: sum of 3 quarters · filed 2021-08-06 | $216.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $109.00K derived: sum of 2 quarters · filed 2021-08-06 | $163.00K 10-Q · filed 2020-11-09 | $208.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $110.00K 10-Q · filed 2021-08-06 | $155.00K derived: sum of 3 quarters · filed 2021-08-06 | $201.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $54.00K 10-Q · filed 2021-05-10 | $99.00K derived: sum of 2 quarters · filed 2021-05-10 | $145.00K derived: sum of 3 quarters · filed 2021-05-10 | $190.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $91.00K derived: sum of 2 quarters · filed 2021-03-01 | $136.00K derived: sum of 3 quarters · filed 2021-03-01 | $182.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $91.00K derived: sum of 2 quarters · filed 2020-11-09 | $137.00K 10-Q · filed 2020-11-09 | $174.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $91.00K 10-Q · filed 2020-08-10 | $128.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $46.00K 10-Q · filed 2020-05-11 | $83.00K derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $135.00K 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $98.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $125.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |